phenobarbital will lower the extent or effect of eltrombopag by impacting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Keep track of.Steer clear of; coadministration with CYP3A inducers may well lead to reduced plasma concentrations of elvitegravir and/or simply a concomitantly administered protease inhibitor and result in loss of therapeutic r